S. Ernst

发表

Characterization of the inhibition of hepatitis C virus entry by In vitro–generated and patient‐derived oxidized low‐density lipoprotein

M. Manns, S. Ciesek, T. Pietschmann, 2013, Hepatology.

O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

C. Yurdaydın, H. Dienes, S. Zeuzem, 2014 .

Perioperative Perfusion of Allografts with Anti-Human T-lymphocyte Globulin Does Not Improve Outcome Post Liver Transplantation—A Randomized Placebo-Controlled Trial

M. Maglione, A. Sattler, S. Schneeberger, 2021, Journal of clinical medicine.

P0668 : On-treatment HBsAg kinetics to predict long-term HDV RNA response to peg-IFNa treatment of hepatitis delta

M. Manns, C. Yurdaydın, A. Koch, 2015 .

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta

M. Manns, C. Yurdaydın, H. Dienes, 2014, PloS one.

Graft Pre-conditioning by Peri-Operative Perfusion of Kidney Allografts With Rabbit Anti-human T-lymphocyte Globulin Results in Improved Kidney Graft Function in the Early Post-transplantation Period—a Prospective, Randomized Placebo-Controlled Trial

M. Maglione, A. Sattler, A. Kühl, 2018, Front. Immunol..

Investigating a biomarker‐driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C‐terminal propeptide of procollagen type I (DROP‐PIP trial)

W. Paulus, B. Pieske, C. Tschöpe, 2018, European journal of heart failure.

TGF-beta superfamily member activin A acts with BDNF and erythropoietin to improve survival of spiral ganglion neurons in vitro

A. Kral, T. Stöver, A. Warnecke, 2013, Neuropharmacology.

Interaction of Interleukin-17A with a Th2 Response in a Mouse Model of Allergic Airway Inflammation

K. Peters, M. Peters, S. Ernst, 2023, Cells.